Antinociceptive effects of NCX-701 (nitro-paracetamol) in neuropathic rats: Enhancement of antinociception by co-administration with gabapentin

British Journal of Pharmacology

Volumn 158, Issue 2, 2009, Pages 601-609

  Curros Criado, M Mar ^a   Herrero, Juan F ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

COX; Electrophysiology; Hyperalgesia; NO NSAIDs; Pain; Spinal cord

Indexed keywords

GABAPENTIN; NCX 701; NITROPARACETAMOL; PARACETAMOL; PARACETAMOL DERIVATIVE; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; ELECTROSTIMULATION; MALE; MECHANICAL STIMULATION; NEUROPATHIC PAIN; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE UNIT ACTIVITY; SPINAL CORD NERVE CELL;

ACETAMINOPHEN; AMINES; ANALGESICS; ANIMALS; CYCLOHEXANECARBOXYLIC ACIDS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; GAMMA-AMINOBUTYRIC ACID; INJECTIONS, INTRAVENOUS; INJECTIONS, SPINAL; MALE; NEURALGIA; NITRATES; PAIN MEASUREMENT; RATS; RATS, WISTAR; SPINAL CORD;

EID: 69549086476     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00343.x     Document Type: Article

References (36)

1. Al-Swayeh OA, Clifford RH, Del Soldato P, Moore PK (2000). A comparison of the anti-inflammatory and anti-nociceptive activity of nitroaspirin and aspirin. Br J Pharmacol 129 : 343 350.
2. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edition (2008 revision). Br J Pharmacol 153 (Suppl. 2 S1 S209.
3. Bannwarth B, Netter P, Pourel J, Royer RJ, Gaucher A (1989). Clinical pharmacokinetics of nonsteroidal anti-inflammatory drugs in cerebrospinal fluid. Biomed Pharmacother 43 : 121 126. (Pubitemid 19099503)
4. Barraco RA, Marcantonio DR, Phillis JW, Campbell WR (1987). The effects of parenteral injections of adenosine and its analogs on blood pressure and heart rate in the rat. Gen Pharmacol 18 : 405 416.
5. Curros-Criado MM, Herrero JF (2005). The antinociceptive effects of the systemic adenosine A1 receptor agonist CPA in the absence and in the presence of spinal cord sensitization. Pharmacol Biochem Behav 82 : 721 726.
6. Davies SN, Lodge D (1987). Evidence for the involvement of N-methylaspartate receptors in 'wind-up' of class 2 neurons in the dorsal horn of the rat. Brain Res 424 : 402 406.
7. De Felipe C, Herrero JF, O'Brieny JA, Palmery JA, Doyley CA, Smith AJH et al. (1998). Altered nociception, analgesia and aggression in the mice lacking the substance P receptor. Nature 392 : 394 397.
8. De Vry J, Kuhl E, Franken-Kunkel P, Eckel G (2004). Pharmacological characterization of the chronic constriction injury model of neuropathic pain. Eur J Pharmacol 491 : 137 148.
9. Del Soldato P, Sorrentino R, Pinto A (1999). NO-aspirins: a class of new anti-inflammatory and antithrombotic agents. Trends Pharmacol Sci 20 : 319 323.
10. Dickenson AH, Sullivan AF (1987). Evidence for a role of the NMDA receptor in the frequency dependent potentiation of deep rat dorsal horn nociceptive neurons following C fibre stimulation. Neuropharmacology 26 : 1235 1238.
11. Evoniuk G, Von Borstel RW, Wurtman RJ (1987). Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl) theophylline. J Pharmacol Exp Ther 240 : 428 432. (Pubitemid 17018422)
12. Fiorucci S (2001). NO-releasing NSAIDs are caspase inhibitors. Trends in Inmunology 22 : 232 235.
13. Gaitan G, Del Soldato P, Herrero JF (2003). Low doses of nitroparacetamol or dexketoprofen trometamol enhance fentanyl antinociceptive activity. Eur J Pharmacol 481 : 181 188.
14. Gaitan G, Ahuir FJ, Herrero JF (2005). Enhancement of fentanyl antinociception by subeffective doses of nitroparacetamol (NCX-701) in acute nociception and in carrageenan-induced monoarthritis. Life Sci 77 : 85 95.
15. Herrero JF, Cervero F (1996a). Changes in nociceptive reflex facilitation during carrageenan-induced arthritis. Brain Res 717 : 62 68.
16. Herrero JF, Cervero F (1996b). Supraspinal influences on the facilitation of rat nociceptive reflexes induced by carrageenan monoarthritis. Neurosci Lett 209 : 21 24.
17. Herrero JF, Curros-Criado MM (2008). Antinociceptive effects of NCX-701 (nitroparacetamol) in neuropathic rats. Enhancement of antinociception by co-administration with gabapentin. 38th Annual Meeting, Society for Neuroscience, Washintong DC. Program No. 773.12/NN6.
18. Herrero JF, Headley PM (1991). The effects of sham and full spinalization on the systemic potency of μ- and k-opioids on spinal nociceptive reflexes in rats. Br J Pharmacol 104 : 166 170.
19. Herrero JF, Laird JMA, Lopez-Garcia JA (2000). Wind-up of spinal cord neurons and pain sensation: much ado about something? Prog Neurobiol 61 : 169 203.
20. Jensen TS (2002). Anticonvulsants in neuropathic pain: rationale and clinical evidence. Eur J Pain 6 (Suppl. A 61 68.
21. Kiss JP, Vizi ES (2001). Nitric oxide: a novel link between synaptic and nonsynaptic transmission. Trends Neurosci 24 : 211 215.
22. Lindner MD, Bourin C, Chen P, McElroy JF, Leet JE, Hogan JB et al. (2006). Adverse effects of gabapentin and lack of anti-allodynic efficacy of amitriptyline in the streptozotocin model of painful diabetic neuropathy. Exp Clin Psychopharmacol 14 : 42 51.
23. Moulin DE, Clark AJ, Gilron I, Ware MA, Watson CP, Sessle BJ et al. (2007). Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society. Pain Res Manag 12 : 13 21.
24. Ochs HR, Greenblatt DJ, Abernethy DR, Arendt RM, Gerloff J, Eichelkraut W et al. (1985). Cerebrospinal fluid uptake and peripheral distribution of centrally acting drugs: relation to lipid solubility. J Pharm Pharmacol 37 : 428 431.
25. Romero-Sandoval A, Mazarío J, Herrero JF (2001). Comparison of the analgesic effects of paracetamol and NO-paracetamol in rat single motor units. Inflamm Res 50 : S211.
26. Romero-Sandoval EA, Mazario J, Howat D, Herrero JF (2002). NCX-701 (nitroparacetamol) is an effective antinociceptive agent in rat withdrawal reflexes and wind-up. Br J Pharmacol 135 : 1556 1562.
27. Romero-Sandoval EA, Del Soldato P, Herrero JF (2003). The effects of sham and full spinalization on the antinociceptive effects of NCX-701 (nitroparacetamol) in monoarthritic rats. Neuropharmacology 45 : 412 419.
28. Romero-Sandoval EA, Curros-Criado MM, Gaitan G, Molina C, Herrero JF (2007). Nitroparacetamol (NCX-701) and pain: first in a series of new analgesics. CNS Drug Rev 13 : 279 295.
29. Sawynok J, Liu XJ (2003). Adenosine in the spinal cord and periphery: release and regulation of pain. Prog Neurobiol 69 : 313 340.
30. Seltzer Z, Dubner R, Shir Y (1990). A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 43 : 205 218.
31. Solano RE, Herrero JF (1997). Cutaneous responsiveness of rat single motor units activated by natural stimulation. J Neurosci Methods 73 : 135 140.
32. Tallarida RJ (2001). Drug synergism: its detection and applications. J Pharmacol Exp Ther 298 : 865 872.
33. Tallarida RJ, Porreca F, Cowan A (1989). Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 45 : 947 961.
34. Tremont-Lukats IW, Megeff C, Backonja MM (2000). Anticonvulsants for neuropathic pain syndromes: mechanisms of action and place in therapy. Drugs 60 : 1029 1052.
35. Wallace JL, Del Soldato P, Cirino G, Muscara MN (1999). Nitric oxide-releasing NSAIDs: GI-safe antithrombotics. Idrugs 2 : 321 326.
36. Yaksh TL, Rudy TA (1976). An improved method for chronic catheterization of the rat spinal subarachnoid space. Physiol Behav 17 : 1031 1036.